Tests for New Diabetic System

Medtronic’s www.medtronic.com “MiniMed 670G” system is currently FDA approved in the U.S for people with type 1 diabetes that are 14 years of age or older. Medtronic has just announced that new data obtained from their at-home pediatric study examining the use of the MiniMed 670G in patients 7- 13 presented at the “Advanced Technologies & Treatments for Diabetes International Conference” in Austria, has shown positive results. (more…)

Game Changers Help Stroke Patients

FDA https://www.fda.gov has given Viz.ai Inc. http://www.Viz.ai approval for their clinical decision support software designed to analyze computed tomography results. The company will now be able to be market the software to use to alert providers when dealing with a potential stroke in patients. The technology is intended to be used by neurovascular specialists such as vascular neurologists, neuro-interventional specialists, or other professionals with similar training. (more…)

Using Tech to Predict Injuries

The Air Force School of Aerospace Medicine (USAFSAM) located at Wright Patterson Air Force Base in Ohio www.wpafb.af.mil has studied the use of the new Dynamic Athletic Research Institute’s (DARI) 3D technology to predict injuries before they happen. The DARI system looks at how a person moves their body while performing functional tasks and then is able to predict where an injury might occur up to two weeks before it might happen. (more…)

Achieving Opioid Management

Michael Kanter MD Executive Vice President of Quality and Chief Quality Officer for the Permanente Federation https://permanente.org and Medical Director of Quality and Clinical Analysis for the Southern California Permanente Medical Group https://permanente.org, took part in a discussion on opioid management. The event sponsored by the Duke Robert J. Margolis MD Center for Health Policy was held at the National Press Club on February 15, 2018. (more…)

Studying Treatments for Parkinson’s

The University of Maryland Medicine https://www.umm.edu is leading a phase 3 study to test the safety and efficacy of using MRI-guided focused ultrasound on the brain to treat Parkinson’s disease (PD). This study is the final step before FDA will consider approving the new technology for widespread use as a nonsurgical treatment option to eliminate key motor symptoms of this common neurological condition. (more…)